Reflow Medical, Inc. designs and develops innovative technologies for treating cardiovascular disease. Working with leading physicians to fill unmet clinical needs, Reflow delivers devices used worldwide to treat Critical Limb Threatening Ischemia (CLTI). Their portfolio of peripheral catheters includes the Wingman™ crossing catheter, with an expanded indication for treating CTOs; the Spex™ shapeable support catheter; and the SpexLP, the lowest profile reinforced support catheter. Reflow continues to develop technologies for use in the fight against peripheral artery disease and recently introduced coraCatheters™ for coronary artery disease. Reflow Medical is headquartered in San Clemente, California.